Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The British approach to cholesterol: A reason for lower health costs

Richard Young, MD
Meds
November 27, 2013
Share
Tweet
Share

The American Heart Association and American College of Cardiology recently published new guidelines for screening and treating cholesterol.

In some ways these guidelines are more like the British guidelines. Instead of setting up doctors and patients to fail by calling for certain cholesterol number targets as in the old U.S. guidelines (i.e. LDL level below 100), they instead focus on putting higher risk patients on drugs called statins and then not worrying about the new cholesterol number under treatment. It’s more simply: high risk, take statin; low risk, don’t take statin.

Of course these guidelines don’t come without controversy. Some estimate the number of adults recommended to take statins will double. Others criticize the spreadsheet that comes with the guidelines as exaggerating the true risk of developing heart disease by 75% to 150%.

The other factor that has gotten less press is the definition of high risk, even if the heart disease calculator is accurate. The AHA/ACC definition of high risk is a greater than 7.5% of developing symptomatic heart disease (not death) in 10 years. The British define high risk as a 20% chance in 10 years.

This is clearly a huge difference and it speaks to the underlying cultures of the two countries. The U.S. doctors and the large foundation that supports them err on the side of assuming more is better, and any theoretical benefit — no matter how high the cost — is worth it.

The British err on the side of being sure that the benefits of drug therapy is clearly greater than the risks of adverse events, and they take costs into consideration. Some people are simply at too low a risk to justify the expense and hassle of a lifetime of drugs.

I wrote earlier about explaining why screening and treating people for high cholesterol does not save money, even in the long run.

The British people and their government are willing to tell its healthcare industry that it can’t have everything it wants, and that other societal goods improve health as well. This is one of the many reasons the British people enjoy better health at less than half the cost of the U.S.

Richard Young is a physician who blogs at American Health Scare.

Prev

Will a personalized DNA report ever be commonly ordered?

November 27, 2013 Kevin 4
…
Next

Who do you want reading your EKG?

November 27, 2013 Kevin 19
…

Tagged as: Cardiology, Medications

Post navigation

< Previous Post
Will a personalized DNA report ever be commonly ordered?
Next Post >
Who do you want reading your EKG?

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Richard Young, MD

  • When medical protocol meets family concerns

    Richard Young, MD
  • Patients in Sweden received fewer post-op opioids. Why is that?

    Richard Young, MD
  • Medicine is too complex for computers to keep up with or understand

    Richard Young, MD

More in Meds

  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • The truth about GLP-1 medications for weight loss: What every patient should know

    Nisha Kuruvadi, DO
  • The hidden bias in how we treat chronic pain

    Richard A. Lawhern, PhD
  • Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

    Robert Trent
  • The anesthesia spectrum: Guiding patients through comfort options in oral surgery

    Dexter Mattox, MD, DMD
  • Functional precision oncology: a game changer in cancer therapy

    Chris Apfel, MD, PhD, MBA
  • Most Popular

  • Past Week

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • A world without antidepressants: What could possibly go wrong?

      Tomi Mitchell, MD | Meds
    • Conflicts of interest are eroding trust in U.S. health agencies

      Martha Rosenberg | Policy
    • Precision and personalization: Charting the future of cancer care [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • The silent crisis hurting pain patients and their doctors

      Kayvan Haddadan, MD | Physician
    • What happened to real care in health care?

      Christopher H. Foster, PhD, MPA | Policy
    • Are quotas a solution to physician shortages?

      Jacob Murphy | Education
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
  • Recent Posts

    • Precision and personalization: Charting the future of cancer care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Expert Q&A: Dr. Jared Pelo, ambient clinical pioneer, explains how Dragon Copilot helps clinicians deliver better care

      Jared Pelo, MD & Microsoft & Nuance Communications | Sponsored
    • The lab behind the lens: Equity begins with diagnosis

      Michael Misialek, MD | Policy
    • Venous leak syndrome: a silent challenge faced by all men

      Elliot Justin, MD | Conditions
    • Rethinking patient payments: Why billing is the new frontline of patient care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dreaded question: Do you have boys or girls?

      Pamela Adelstein, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 5 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • A world without antidepressants: What could possibly go wrong?

      Tomi Mitchell, MD | Meds
    • Conflicts of interest are eroding trust in U.S. health agencies

      Martha Rosenberg | Policy
    • Precision and personalization: Charting the future of cancer care [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • The silent crisis hurting pain patients and their doctors

      Kayvan Haddadan, MD | Physician
    • What happened to real care in health care?

      Christopher H. Foster, PhD, MPA | Policy
    • Are quotas a solution to physician shortages?

      Jacob Murphy | Education
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
  • Recent Posts

    • Precision and personalization: Charting the future of cancer care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Expert Q&A: Dr. Jared Pelo, ambient clinical pioneer, explains how Dragon Copilot helps clinicians deliver better care

      Jared Pelo, MD & Microsoft & Nuance Communications | Sponsored
    • The lab behind the lens: Equity begins with diagnosis

      Michael Misialek, MD | Policy
    • Venous leak syndrome: a silent challenge faced by all men

      Elliot Justin, MD | Conditions
    • Rethinking patient payments: Why billing is the new frontline of patient care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dreaded question: Do you have boys or girls?

      Pamela Adelstein, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The British approach to cholesterol: A reason for lower health costs
5 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...